2013 CPhI Pharma Awards - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

2013 CPhI Pharma Awards


CPhI is now accepting applications for the 2013 CPhI Pharma Awards, open to individuals and companies who have developed innovations in pharma over the past year.

About the Awards
For nine years, the CPhI Pharma Awards have recognized thought leadership on a global scale, unveiling top pharma innovators to global trade press during the leading pharmaceutical event.

Learn more about the Awards
Benefits of Entering

Finalists will be notified in September 2013, and will present their innovations on the CPhI show floor on Oct. 22, 2013. The CPhI Pharma Awards ceremony and party are scheduled for the evening of Oct. 22 in the Messe Frankfurt Europa Room.

Categories
Awards are presented in three categories:
Innovation in Formulation
Entries in the Innovation in Formulation category should pertain to the following topics: Drug Delivery, Excipients, Controlled Release, Stability, or Bio Availability.

Innovation in Process Development
Entries in the Innovation in Process Development category should pertain to the following topics: Synthesis, Crystalization, Polymorphism, Catalysts or Green Chemistry.

Innovation in Packaging
Entries in the Innovation in Packaging category should pertain to the following topics: Primary Packaging, Devices & Technology, Patient Compliance, Dispensers, Materials, Counterfeit Technologies.

Learn more about the categories.

Entry Process

The CPhI Pharma Awards are open for pharmaceutical professionals working in roles spanning the entire pharma industry. CPhI Worldwide 2013 exhibitors can enter free of charge. Registered visitors can enter with a €95 application fee. Entrants must submit the appropriate application by Friday, July 26, 2013.

For more information, visit www.cphi.com/awards.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here